-+ 0.00%
-+ 0.00%
-+ 0.00%

*Cytokinetics: Expect to Submit Supplemental NDA for Aficamten in Non-Obstructive HCM in 4Q26 >CYTK

Dow Jones·11/04/2026 21:05:09